首页> 外文OA文献 >Facilitating and inhibiting factors for long-term involvement of patients at outcome conferences--lessons learnt from a decade of collaboration in OMERACT: a qualitative study.
【2h】

Facilitating and inhibiting factors for long-term involvement of patients at outcome conferences--lessons learnt from a decade of collaboration in OMERACT: a qualitative study.

机译:促进和抑制患者长期参与结果会议的因素-从OMERACT十年合作中获得的经验教训:定性研究。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: Several studies have provided insights into the conditions for successful patient involvement in health research. We recently demonstrated that long-term engagement with people with rheumatic conditions in international outcome research led to significant changes in the research agenda in the field of rheumatology. This article explores facilitating and inhibiting factors for long-term involvement of patients as collaborative partners at five Outcome Measures in Rheumatology (OMERACT) conferences. Design: Responsive evaluation, starting with a thematic document analysis of conference proceedings and the grey literature, followed by 38 qualitative interviews. Interview transcripts were subjected to inductive content analysis. Setting: 5 international OMERACT conferences between 2002 and 2012. Participants: Patient delegates (n=16) and professional delegates representing researchers (n=14), pharmaceutical industry and regulators (n=2). Results: Combined review of the document analysis and interview data revealed five main facilitators and three main barriers. Patient engagement as full participants at OMERACT conferences was enhanced by: strong leadership commitment and the presence of change agents, a clear selection procedure, an inclusive consensus-based conference design, individualised and self-organised support, an interactive and encouraging moderation style during discussion groups. Barriers were related to the intensity of the conference programme, scepticism among researchers and doubts about the representativeness of the patient group. Conclusions: This study concludes that developing a sustainable structure for funding, selection and support of patient delegates, as well as adjusting conference design and moderation style, contributes not only towards facilitating direct dialogue between all stakeholders but also towards enhancing mutual understanding and the successful incorporation of the patient perspective in an outcome conference such as OMERACT.
机译:目的:几项研究提供了成功使患者参与健康研究的条件的见识。我们最近证明,与风湿病患者长期参与国际成果研究导致风湿病学领域研究议程发生重大变化。本文探讨了在五个风湿病学成果措施(OMERACT)会议上,作为长期合作伙伴的患者长期参与的促进和抑制因素。设计:响应式评估,首先是对会议记录和灰色文献的专题文件分析,然后是38次定性访谈。采访笔录进行归纳性内容分析。地点:2002年至2012年之间,举行了5次OMERACT国际会议。参加者:患者代表(n = 16)和代表研究人员的专业代表(n = 14),制药业和监管机构(n = 2)。结果:对文档分析和访谈数据的综合审查显示了五个主要的促进因素和三个主要的障碍。通过以下方式增强了患者在OMERACT会议上作为正式参与者的参与度:强有力的领导承诺和变革推动者的存在,明确的选择程序,基于共识的包容性会议设计,个性化和自组织的支持,讨论期间的互动性和鼓励性的主持人风格组。障碍与会议计划的强度,研究人员的怀疑以及对患者群体代表性的怀疑有关。结论:这项研究得出的结论是,为患者代表的资金,选择和支持建立可持续的结构,以及调整会议的设计和主持方式,不仅有助于促进所有利益相关者之间的直接对话,而且还有助于增进相互理解和成功地合并。在诸如OMERACT之类的结果会议中对患者观点的看法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号